Diana Quinlan
About
Diana Quinlan is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Hardware and Architecture.
According to data from OpenAlex, Diana Quinlan has authored 27 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 11 papers in Public Health, Environmental and Occupational Health and 5 papers in Hardware and Architecture. Recurrent topics in Diana Quinlan's work include Hematopoietic Stem Cell Transplantation (16 papers), Acute Lymphoblastic Leukemia research (11 papers) and Acute Myeloid Leukemia Research (10 papers). Diana Quinlan is often cited by papers focused on Hematopoietic Stem Cell Transplantation (16 papers), Acute Lymphoblastic Leukemia research (11 papers) and Acute Myeloid Leukemia Research (10 papers). Diana Quinlan collaborates with scholars based in Canada, United States and Austria. Diana Quinlan's co-authors include Douglas A. Stewart, James A. Russell, Börje S. Andersson, Nizar J. Bahlis, M. Ahsan Chaudhry, Donald G. Morris, Peter Duggan, Jeffrey A. Russell, Jan Storek and Christopher Brown and has published in prestigious journals such as Blood, Bone Marrow Transplantation and Biology of Blood and Marrow Transplantation.
In The Last Decade
Diana Quinlan
25 papers receiving 876 citations
Peers
Diana Quinlan
Sahra Ali United Kingdom
Masaki Yamamoto Japan
Martín Martín Indonesia
Yi Zhao China
J. Rees United Kingdom
Arihant Jain India
Ji Hyung Hong South Korea
Elaine Sobral da Costa Brazil
S Peller Israel
Hoang Q. Nguyen United States
Citations per year, relative to Diana Quinlan Diana Quinlan (= 1×)
peers
Sahra Ali
Countries citing papers authored by Diana Quinlan
Since
Specialization
Citations
This map shows the geographic impact of Diana Quinlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Quinlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Quinlan more than expected).
Fields of papers citing papers by Diana Quinlan
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Diana Quinlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Quinlan. The network helps show where Diana Quinlan may publish in the future.
Co-authorship network of co-authors of Diana Quinlan
This figure shows the co-authorship network connecting the top 25 collaborators of Diana Quinlan. A scholar is included among the top collaborators of Diana Quinlan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Quinlan. Diana Quinlan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Jones, David T., Loree Larratt, Robert Turner, et al.. (2013). Progressive vs Non-Progressive Onset of Chronic GVHD After ATG Prophylaxis Is Highly Predictive of Outcome. Biology of Blood and Marrow Transplantation. 19(2). S327–S327.
2.
Ng, Ella S.M., M. Ahsan Chaudhry, Judy Wu, et al.. (2011). Development and Validation of a Test Dose Strategy for Once-Daily i.v. Busulfan: Importance of Fixed Infusion Rate Dosing. Biology of Blood and Marrow Transplantation. 18(2). 295–301.
3.
Ugarte-Torres, Alejandra, Mette Hoegh-Petersen, Yiping Liu, et al.. (2010). Donor Serostatus Has an Impact on Cytomegalovirus-Specific Immunity, Cytomegaloviral Disease Incidence, and Survival in Seropositive Hematopoietic Cell Transplant Recipients. Biology of Blood and Marrow Transplantation. 17(4). 574–585.
4.
Williamson, Tyler, M. Ahsan Chaudhry, Mary Lynn Savoie, et al.. (2010). Influence of comorbidities on transplant outcomes in patients aged 50 years or more after myeloablative conditioning incorporating fludarabine, BU and ATG. Bone Marrow Transplantation. 46(8). 1077–1083.
5.
Russell, James A., William Irish, M. Ahsan Chaudhry, et al.. (2009). The Addition of 400 cGY Total Body Irradiation to a Regimen Incorporating Once-Daily Intravenous Busulfan, Fludarabine, and Antithymocyte Globulin Reduces Relapse Without Affecting Nonrelapse Mortality in Acute Myelogenous Leukemia. Biology of Blood and Marrow Transplantation. 16(4). 509–514.
6.
Geddes, Michelle, Diana Quinlan, M. Ahsan Chaudhry, et al.. (2008). High Busulfan Exposure Is Associated with Worse Outcomes in a Daily i.v. Busulfan and Fludarabine Allogeneic Transplant Regimen. Biology of Blood and Marrow Transplantation. 14(2). 220–228.
7.
Bredeson, Christopher, Mei‐Jie Zhang, Afiba Manza‐A. Agovi, et al.. (2008). Outcomes following HSCT Using Fludarabine, Busulfan, and Thymoglobulin: A Matched Comparison to Allogeneic Transplants Conditioned with Busulfan and Cyclophosphamide. Biology of Blood and Marrow Transplantation. 14(9). 993–1003.
8.
Russell, James A., Qiuli Duan, M. Ahsan Chaudhry, et al.. (2008). Transplantation from Matched Siblings Using Once-Daily Intravenous Busulfan/Fludarabine with Thymoglobulin: A Myeloablative Regimen with Low Nonrelapse Mortality in All But Older Patients with High-Risk Disease. Biology of Blood and Marrow Transplantation. 14(8). 888–895.
9.
Russell, James A., A. Robert Turner, Loree Larratt, et al.. (2007). Adult Recipients of Matched Related Donor Blood Cell Transplants Given Myeloablative Regimens Including Pretransplant Antithymocyte Globulin Have Lower Mortality Related to Graft-versus-Host Disease: A Matched Pair Analysis. Biology of Blood and Marrow Transplantation. 13(3). 299–306.
10.
Russell, James A., Mary Lynn Savoie, A. Robert Turner, et al.. (2007). Allogeneic Transplantation for Adult Acute Leukemia in First and Second Remission with a Novel Regimen Incorporating Daily Intravenous Busulfan, Fludarabine, 400 CGY Total-Body Irradiation, and Thymoglobulin. Biology of Blood and Marrow Transplantation. 13(7). 814–821.
11.
Panas, Thomas, Diana Quinlan, & Richard Vuduc. (2007). Analyzing and Visualizing Whole Program Architectures. University of North Texas Digital Library (University of North Texas).
12.
Savoie, Mary Lynn, Ahsan Chaudhry, Douglas A. Stewart, et al.. (2006). Total Body Irradiation (TBI) Added to Fludarabine/Busulfan/Antithymocyte Gobulin (FLUBUP/ATG) Conditioning Increases Overall Survival and Relapse-Free Survival in Patients with Acute Myeloid Leukemia (AML) Receiving Allogeneic Stem Cell Transplants.. Blood. 108(11). 3010–3010.
13.
Chaudhry, Ahsan, et al.. (2006). Improving the Pharmacokinetic Analysis of the Once Daily IV Busulfan Regimen for Allogeneic Stem-Cell Transplants: A Scientific Method Modification.. Blood. 108(11). 2941–2941.
14.
Savoie, Mary Lynn, M. Ahsan Chaudhry, Douglas A. Stewart, et al.. (2005). The Influence of Adding Low-Dose (400cGy) Total Body Irradiation (TBI) on Outcomes of Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukaemia (AML) with Myeloablative Conditioning Incorporating Daily Intravenous Busulfan, Fludarabine and Low-Dose Antithymocyte Globulin.. Blood. 106(11). 2733–2733.
15.
Andersson, Börje S., et al.. (2004). Individualized Once-Daily Dosing of Intravenous Busulfan: A Pharmacokinetic Study in Patients Undergoing Conditioning for Allogeneic Stem Cell Transplantation.. Blood. 104(11). 98–98.
16.
Quinlan, Diana, et al.. (2004). Mobilized blood cells vs bone marrow harvest: experience compared in 171 donors with particular reference to pain and fatigue. Bone Marrow Transplantation. 33(7). 709–713.
17.
Russell, Jeffrey A., Hai T. Tran, Diana Quinlan, et al.. (2002). Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: Study of pharmacokinetics and early clinical outcomes. Biology of Blood and Marrow Transplantation. 8(9). 468–476.
18.
Quinlan, Diana. (2001). ROSETTA: the compile-time recognition of object-oriented library abstractions and their use within user applications. University of North Texas Digital Library (University of North Texas).
19.
Quinlan, Diana. (2001). Rose Compiler Support for Object-Oriented Frameworks. Parallel Processing Letters. 10(2-3). 215–226.
20.
Luider, Joanne, Christopher Brown, Diana Quinlan, et al.. (1997). Factors Influencing Yields of Progenitor Cells for Allogeneic Transplantation: Optimization of G-CSF Dose, Day of Collection, and Duration of Leukapheresis. Journal of Hematotherapy. 6(6). 575–580.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Sahra Ali Breakdown of academic impact, for papers by Masaki Yamamoto Breakdown of academic impact, for papers by Martín Martín Breakdown of academic impact, for papers by Yi Zhao Breakdown of academic impact, for papers by J. Rees Breakdown of academic impact, for papers by Arihant Jain Breakdown of academic impact, for papers by Ji Hyung Hong Breakdown of academic impact, for papers by Elaine Sobral da Costa Breakdown of academic impact, for papers by S Peller Breakdown of academic impact, for papers by Hoang Q. Nguyen